Biochemical, Kinetic and Spectroscopic Characterizations Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Elucidation of Protein Interactions and the Re-Tuning of Porphyrin Electronics for Hydroxylases
University of South Carolina Scholar Commons Theses and Dissertations 2017 Elucidation Of Protein Interactions And The Re- Tuning Of Porphyrin Electronics For Hydroxylases Steven Charles Ratigan University of South Carolina Follow this and additional works at: https://scholarcommons.sc.edu/etd Part of the Chemistry Commons Recommended Citation Ratigan, S. C.(2017). Elucidation Of Protein Interactions And The Re-Tuning Of Porphyrin Electronics For Hydroxylases. (Doctoral dissertation). Retrieved from https://scholarcommons.sc.edu/etd/4482 This Open Access Dissertation is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. ELUCIDATION OF PROTEIN INTERACTIONS AND THE RE-TUNING OF PORPHYRIN ELECTRONICS FOR HYDROXYLASES by Steven Charles Ratigan Bachelor of Arts The Citadel, 2005 Bachelor of Science University of South Carolina, 2009 Master of Arts The Citadel, 2012 Submitted in Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy in Chemistry College of Arts and Sciences University of South Carolina 2017 Accepted by: Thomas Makris, Major Professor F. Wayne Outten, Committee Member John Lavigne, Committee Member Zhengqing Fu, Committee Member Cheryl L. Addy, Vice Provost and Dean of the Graduate School © Copyright by Steven Charles Ratigan, 2017 All Rights Reserved. ii DEDICATION I dedicate this work to my family, who have always been there for me. Without their support, my time in academia would have been much more difficult. I would also like to thank Dr. David Donnell of The Citadel Dept. of Biology for teaching me everything I know about molecular biology, which proved to be a huge help early on in this program. -
Phylogenetic Screening for Possible Novel
11 M060072591U NORTH-WEST UNIVERSITY tilt• YUNIBESITI YA BOKONE•BOPHIRIMA NOOROVVE S-UNIVERSITEIT PHYLOGENETIC SCREENING FOR POSSIBLE NOVEL ANTIBIOTIC PRODUCING ACTINOMYCETES FROM RHIZOSPHERIC SOIL SAMPLES COLLECTED FROM NGAKA MODIRI MOLEMA DISTRICT IN NORTH WEST PROVINCE, SOUTH AFRICA I BY MOBOLAJI FELICIA ADEGBOYE A thesis submitted in fulfilment of the requirements for the degree of DOCTOR OF PHILOSOPHY (BIOLOGY) DEPARTMENT OF BIOLOGICAL SCIENCES FACULTY OF SCIENCE, AGRICULTURE AND TECHNOLOGY NORTH-WEST UNIVERSITY, MAFIKENG CAMPUS SOUTH AFRICA Supervisor: Professor Olubukola 0. Babalola 2014 LIBRARY o MAFIKENG CAMPUS CALL NO.: 2021 -02- 0 4 DECLARATION I, the undersigned, declare that this thesis submitted to the North-West University for the degree of Doctor of Philosophy in Biology in the Faculty of Science, Agriculture and Technology, School of Environmental and Health Sciences, and the work contained herein is my original work with exemption to the citations and that this work has not been submitted at any other University in partial or entirely for the award of any degree. Name: Mobolaji Felicia Adegboye Signature: .....~ •·· ··· ····· ·· .. ··············· ..... Date: .... ~S.. .. ....a~ ·1·· ·'.}Q~i; ... ............ .... DEDICATION This work is dedicated to Almighty God for His faithfulness over my life and for making my helpers to be many. ii ACKNOWLEDGEMENTS I would like to express my deepest thanks, gratitude and appreciation to my supervisor and mentor, Prof. Olubukola 0. Babalola for giving me the opportunity to pursue my doctoral degree under her supervision and for her encouragement, help and kind support. Her invaluable advice, suggestions, discussions and guidance were a real support to me. I acknowledge with honour and gratitude the International Foundation for Science (IFS) for research grant (F/5330-1 ), Connect Africa Scholarship Award, H3ABioNet/SANBio Scholarship and North-West University for offering me bursary/scholarship award to pursue the PhD degree. -
© 2016 Shiliang Tian
© 2016 Shiliang Tian PROTEIN ENGINEERING USING AZURIN AS THE SCAFFOLD: CAPTURING AND STUDYING NOVEL METAL-SULFENATE AND METAL-NO SPECIES BY SHILIANG TIAN DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate College of the University of Illinois at Urbana-Champaign, 2016 Urbana, Illinois Doctoral Committee: Professor Yi Lu, Chair Professor Thomas B. Rauchfuss Professor Wilfred A. van der Donk Assistant Professor Alison R. Fout Abstract Metalloproteins account for nearly half of all proteins in nature. Metal ions play important roles in catalyzing numerous important biological processes that necessary to sustain life on the planet, such as photosynthesis, respiration and nitrogen fixation. Much effort has been made to understand the relationship between structures and functions of metalloproteins. Although significant progresses have been made to obtain the knowledge of how metalloproteins work, the ultimate test is to use this knowledge to design new metallproteins that reproduce the structures and functions of native proteins. Protein redesign strategy is one of the most effective approaches in the design and engineering of artificial metalloenzymes. The advantage of a protein redesign strategy is that it can bypass the problem of developing a stable protein fold because many native proteins have remarkable adaptability for changes. The use of small, stable, easy-to- make, and well-characterized blue copper protein azurin as scaffold to design novel metal binding sites has been proven to be a promising way for protein redesign. Not only can its reduction potential be rationally tuned beyond the nature range via secondary coordination sphere engineering, but also the CuA and redox- active nonheme iron sites have been successfully engineered in azurin. -
Supplementary Table 1
Supplemental Table 1. GO terms for the Flavonoid biosynthesis pathway and genes identified through pathway-level co-expression analysis. The ranking is sorted for descending counts within the pathway. The last two columns give the number of genes within or outside the pathway that are annotated with the term listed in the second column. GO id GO term Genes Genes within outside pathway pathway GO:0008372 cellular component unknown 13 28 GO:0016207 4-coumarate-CoA ligase activity 12 0 GO:0008152 metabolism 8 7 GO:0019350 teichoic acid biosynthesis 8 0 GO:0009234 menaquinone biosynthesis 8 0 GO:0009698 phenylpropanoid metabolism 7 0 GO:0009813 flavonoid biosynthesis 7 0 GO:0008299 isoprenoid biosynthesis 6 0 GO:0009507 chloroplast 5 24 GO:0009411 response to UV 4 0 GO:0016706 "oxidoreductase activity, acting on paired donors, with 4 0 incorporation or reduction of molecular oxygen, 2- oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors" GO:0009058 biosynthesis 3 2 GO:0009699 phenylpropanoid biosynthesis 3 1 GO:0008415 acyltransferase activity 3 1 GO:0004315 3-oxoacyl-[acyl-carrier protein] synthase activity 3 0 GO:0006633 fatty acid biosynthesis 3 0 GO:0005739 mitochondrion 2 7 GO:0005783 endoplasmic reticulum 2 1 GO:0009695 jasmonic acid biosynthesis 2 1 GO:0009611 response to wounding 2 1 GO:0005506 iron ion binding 2 1 GO:0016216 isopenicillin-N synthase activity 2 0 GO:0005777 peroxisome 2 0 GO:0045430 chalcone isomerase activity 2 0 GO:0009705 vacuolar membrane (sensu Magnoliophyta) 2 0 GO:0004321 -
Cysteine Dioxygenase 1 Is a Metabolic Liability for Non-Small Cell Lung Cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M
bioRxiv preprint doi: https://doi.org/10.1101/459602; this version posted November 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M. Asara3,4, Christian C. Dibble5,6 and Gina M. DeNicola1,* Affiliations: 1 Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 2 Proteomics and Metabolomics Core Facility, Moffitt Cancer Center and Research Institute, Tampa, FL, USA 3 Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA 4 Department of Medicine, Harvard Medical School, Boston, MA, USA 5 Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA 6 Department of Pathology, Harvard Medical School, Boston, MA, USA *Correspondence to: [email protected]. Keywords: KEAP1, NRF2, cysteine, CDO1, sulfite Summary NRF2 is emerging as a major regulator of cellular metabolism. However, most studies have been performed in cancer cells, where co-occurring mutations and tumor selective pressures complicate the influence of NRF2 on metabolism. Here we use genetically engineered, non-transformed primary cells to isolate the most immediate effects of NRF2 on cellular metabolism. We find that NRF2 promotes the accumulation of intracellular cysteine and engages the cysteine homeostatic control mechanism mediated by cysteine dioxygenase 1 (CDO1), which catalyzes the irreversible metabolism of cysteine to cysteine sulfinic acid (CSA). Notably, CDO1 is preferentially silenced by promoter methylation in non-small cell lung cancers (NSCLC) harboring mutations in KEAP1, the negative regulator of NRF2. -
RT² Profiler PCR Array (Rotor-Gene® Format) Human Amino Acid Metabolism I
RT² Profiler PCR Array (Rotor-Gene® Format) Human Amino Acid Metabolism I Cat. no. 330231 PAHS-129ZR For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Rotor-Gene Q, other Rotor-Gene cyclers Format R Description The Human Amino Acid Metabolism I RT² Profiler PCR Array profiles the expression of 84 key genes important in biosynthesis and degradation of functional amino acids. Of the 20 amino acids required for protein synthesis, six of them (arginine, cysteine, glutamine, leucine, proline, and tryptophan), collectively known as the functional amino acids, regulate key metabolic pathways involved in cellular growth, and development, as well as other important biological processes such as immunity and reproduction. For example, leucine activates mTOR signaling and increases protein synthesis, leading to lymphocyte proliferation. Therefore, a lack of leucine can compromise immune function. Metabolic pathways interrelated with the biosynthesis and degradation of these amino acids include vitamin and cofactor biosynthesis (such as SAM or S-Adenosyl Methionine) as well as neurotransmitter metabolism (such as glutamate). This array includes genes for mammalian functional amino acid metabolism as well as genes involved in methionine metabolism, important also for nutrient sensing and sulfur metabolism. Using realtime PCR, you can easily and reliably analyze the expression of a focused panel of genes involved in functional amino acid metabolism with this array. For further details, consult the RT² Profiler PCR Array Handbook. Shipping and storage RT² Profiler PCR Arrays in the Rotor-Gene format are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. -
The Different Catalytic Roles of the Metal Binding Ligands in Human 4- Hydroxyphenylpyruvate Dioxygenase
Citation for published version: Huang, C-W, Liu, H-C, Shen, C-P, Chen, Y-T, Lee, S-J, Lloyd, MD & Lee, H-J 2016, 'The different catalytic roles of the metal- binding ligands in human 4-hydroxyphenylpyruvate dioxygenase', Biochemical Journal, vol. 473, no. 9, pp. 1179-1189. https://doi.org/10.1042/BCJ20160146 DOI: 10.1042/BCJ20160146 Publication date: 2016 Document Version Peer reviewed version Link to publication Publisher Rights Unspecified University of Bath Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 28. Sep. 2021 BIOCHEMICAL JOURNAL ACCEPTED MANUSCRIPT The different catalytic roles of the metal binding ligands in human 4- hydroxyphenylpyruvate dioxygenase Chih‐Wei Huang, Hsiu‐Chen Liu, Chia‐Pei Shen, Yi‐Tong Chen, Sung‐Jai Lee, Matthew D. Lloyd, and Hwei‐Jen Lee 4‐Hydroxylphenylpyruvate dioxygenase (HPPD) is a non‐haem iron(II)‐dependent oxygenase that catalyzes the conversion of 4‐hydroxylphenylpyruvate (HPP) to homogentisate (HG). In the active site, a strictly conserved 2‐His‐1‐Glu facial triad coordinates the iron ready for catalysis. Substitution of these residues resulted in about a 10‐fold decrease in the metal binding affinity, as measured by isothermal titration calorimetry, and a large reduction in enzyme catalytic efficiencies. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Microorganisms: a Potential Source of Bioactive Molecules for Antioxidants and Antimicrobial Applications
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 4 January 2021 doi:10.20944/preprints202101.0025.v1 Review Microorganisms: A Potential Source of Bioactive molecules for Antioxidants and Antimicrobial Applications Alka Rani 1#, Khem Chand Saini 1#, Felix Bast 1, Sanjeet Mehariya 2, Shashi Kant Bhatia 3, Roberto Lavecchia 2 and Antonio Zuorro 2,* 1 Department of Botany, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, Pun- jab, India -151001; [email protected] (A.R.); [email protected] (K.C.S.); [email protected] (F.B.) 2 Department of Chemical Engineering, Materials and Environment, Sapienza University of Rome, 00184 Rome, Italy; [email protected] (R.L.) 3 Department of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea; [email protected] (S.K.B.) * Correspondence: [email protected] (S.M.); [email protected] (A.Z.) Abstract: Oxidative stress is an elevated intracellular level of free oxygen radicals that cause lipid peroxidation, protein denaturation, DNA hydroxylation, and apoptosis, ultimately negotiating cells viability. Antioxidants can scavenge such free radicals, thus reducing the oxidative stress and even- tually prevent cellular damage. Medicinal plants, fruits, and spices remain the prioritized sources of antioxidants and antimicrobial properties since the time immemorial, but in contrast to plants, mi- croorganisms can be grown at a faster rate under controlled conditions. They are non-toxic, non- carcinogenic, and biodegradable as compared to synthetic antioxidants. Microorganisms including actinomycetes, archaea, bacteria, protozoa, yeast, and fungi are auspicious source of vital bioactive compounds. The list comprises ample of bioactive components from microorganisms. -
The Nature of O2 Activation by the Ethylene-Forming Enzyme 1-Aminocyclopropane-1-Carboxylic Acid Oxidase
The nature of O2 activation by the ethylene-forming enzyme 1-aminocyclopropane-1-carboxylic acid oxidase Liviu M. Mirica and Judith P. Klinman* Departments of Chemistry and Molecular and Cell Biology, University of California, Berkeley, CA 94720 Contributed by Judith P. Klinman, December 10, 2007 (sent for review November 15, 2007) Ethylene is a plant hormone important in many aspects of plant studied extensively, and it generally is accepted that O2 activation growth and development such as germination, fruit ripening, and at the iron center is linked to oxidative decarboxylation of the senescence. 1-Aminocyclopropane-1-carboxylic acid (ACC) oxidase ␣KG, ultimately forming an FeIVAO species as the reactive (ACCO), an O2-activating ascorbate-dependent nonheme iron en- intermediate (14–17). This high-valent Fe/O2 species functions zyme, catalyzes the last step in ethylene biosynthesis. The O2 as a ‘‘generic’’ oxidant for a wide range of oxidation/oxygenation activation process by ACCO was investigated using steady-state reactions. kinetics, solvent isotope effects (SIEs), and competitive oxygen In contrast to the ␣KG-dependent enzymes, where ␣KG kinetic isotope effects (18O KIEs) to provide insights into the nature rather than substrate binds to the metal center, spectroscopic of the activated oxygen species formed at the active-site iron studies of ACCO have shown that ACC coordinates to the iron center and its dependence on ascorbic acid. The observed large 18O center via both its amino and carboxylate groups (10, 18).† This -KIE of 1.0215 ؎ 0.0005 strongly supports a rate-determining step finding implies a distinctly different mode for reductant inter formation of an FeIVAO species, which acts as the reactive inter- action with ACCO than for most other nonheme iron enzymes. -
Mechanistic Study of Cysteine Dioxygenase, a Non-Heme
MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE, A NON-HEME MONONUCLEAR IRON ENZYME by WEI LI Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Student Name Wei Li All Rights Reserved Acknowledgements I would like to thank Dr. Pierce for your mentoring, guidance and patience over the five years. I cannot go all the way through this without your help. Your intelligence and determination has been and will always be an example for me. I would like to thank my committee members Dr. Dias, Dr. Heo and Dr. Jonhson- Winters for the directions and invaluable advice. I also would like to thank all my lab mates, Josh, Bishnu ,Andra, Priyanka, Eleanor, you all helped me so I could finish my projects. I would like to thank the Department of Chemistry and Biochemistry for the help with my academic and career. At Last, I would like to thank my lovely wife and beautiful daughter who made my life meaningful and full of joy. July 11, 2014 iii Abstract MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE A NON-HEME MONONUCLEAR IRON ENZYME Wei Li, PhD The University of Texas at Arlington, 2014 Supervising Professor: Brad Pierce Cysteine dioxygenase (CDO) is an non-heme mononuclear iron enzymes that catalyzes the O2-dependent oxidation of L-cysteine (Cys) to produce cysteine sulfinic acid (CSA). CDO controls cysteine levels in cells and is a potential drug target for some diseases such as Parkinson’s and Alzhermer’s. -
Cysteamine: an Old Drug with New Potential
Drug Discovery Today Volume 18, Numbers 15/16 August 2013 REVIEWS POST SCREEN Cysteamine: an old drug with new potential Reviews 1,2 3 1,2,4 Martine Besouw , Rosalinde Masereeuw , Lambert van den Heuvel and 1,2 Elena Levtchenko 1 Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium 2 Laboratory of Pediatrics, Department of Development & Regeneration, Catholic University Leuven, Belgium 3 Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands 4 Laboratory for Genetic, Endocrine and Metabolic Disorders, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Cysteamine is an amino thiol with the chemical formula HSCH2CH2NH2. Endogenously, cysteamine is derived from coenzyme A degradation, although its plasma concentrations are low. Most experience with cysteamine as a drug originates from the field of the orphan disease cystinosis, in which cysteamine is prescribed to decrease intralysosomal cystine accumulation. However, over the years, the drug has been used for several other applications both in vitro and in vivo. In this article, we review the different applications of cysteamine, ending with an overview of ongoing clinical trials for new indications, such as neurodegenerative disorders and nonalcoholic fatty liver disease (NAFLD). The recent development of an enteric-coated cysteamine formulation makes cysteamine more patient friendly and will extend its applicability for both old and new indications. Endogenous cysteamine production cysteine, it is oxidized into taurine by hypotaurine dehydrogenase Cysteamine (synonyms: b-mercaptoethylamine, 2-aminoetha- (Fig. 1b). Taurine is excreted either in urine, or in feces in the form nethiol, 2-mercaptoethylamine, decarboxycysteine, thioethano- of bile salts [3].